Thymidine-5'-triphosphate (Pubchem)
dNTP Pool
Pool identifier POOL001001
Members of this Pool
Members of control pools
POOL000998
Last modified: 10/Sep/2021
Results
Publication
Thientosapol ES, Bosnjak D, Durack T, Stevanovski I, van Geldermalsen M, Holst J, Jahan Z, Shepard C, Weninger W, Kim B, Brink R, Jolly CJ: SAMHD1 enhances immunoglobulin hypermutation by promoting transversion mutation., Proc Natl Acad Sci U S A, 2018

PubMed PMCID
Value 0.6146
Dimension pmol/106 cell
Error Error not provided.
Data presentation in publication diagram
Source
Source organism mouse (Mus musculus)
Taxonomy 10090
Animal strain C57BL/6 mice
Sample source tissue
Tissue type splenocytes
Cell line/type as in publication C57BL/6; Samhd1 +/∆25
Compartment whole cell
Experiment Details
Measurement type dNTP incorporation assay
Extraction method methanol
Remarks to measurement type with HIV-1 reverse transcriptase
Growth conditions splenocytes were activated with 20 μg/mL S. typhosa LPS plus 20 ng/mL mouse IL-4 for 24 h; activated cells were then transduced with pMiG-derived retroviruses that expressed mKO2-cdt; dNTPmeasurement was 2 days after transfection from mKO2+ cells; G1 phase cells
Treatment
Drug/stress type drug
Applied drug LPS, IL-4
Genes and Proteins
Gene name SAMHD1
Gene identifier 56045
Protein name Deoxynucleoside triphosphate triphosphohydrolase SAMHD1
Protein identifier Q60710
Genetic manipulation/variation mutation
Mutation in protein 25-bp frame-shift deletions within Exon 1, heterozygous mutation, fusion protein